Zobrazeno 1 - 10
of 29
pro vyhledávání: '"James S, Cochran"'
Autor:
Andrew W. Wood, Mariela Martinez, Elie Kaplan-Marans, Ariel Schulman, Elliot Dubowitch, James S. Cochran
Publikováno v:
Journal of Endourology. 36:231-235
Purpose: Aquablation, prostatic urethral lift (PUL), and transurethral water vapor therapy (TWVT) have demonstrated efficacy for the treatment of benign prostatic hyperplasia (BPH). Our objective w...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e625f4f56cba0207de64311262c0e208
https://doi.org/10.1089/end.2021.0455
https://doi.org/10.1089/end.2021.0455
Autor:
James S. Cochran, Andrew W. Wood, Michael Lee, Elie Kaplan-Marans, Ariel Schulman, Elliot Dubowitch
Publikováno v:
Journal of Urology. 206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74302a8bee1880779746c9a32c5f0ab3
https://doi.org/10.1097/ju.0000000000001983.19
https://doi.org/10.1097/ju.0000000000001983.19
Autor:
Michael Lee, Andrew W. Wood, Elliot Dubowitch, Elie Kaplan-Marans, Ariel Schulman, James S. Cochran
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Urolift and Rezum have demonstrated efficacy as minimally invasive surgical therapies (MIST) for the treatment of benign prostatic hyperplasia (BPH). Both modalities can ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::005b588f2e9003e38b7a4e5734554bd6
https://doi.org/10.1097/ju.0000000000002007.04
https://doi.org/10.1097/ju.0000000000002007.04
Publikováno v:
Bioacoustics. 27:273-294
Elucidating the structure and function of joint vocal displays (e.g. duet, chorus) recorded with a conventional microphone has proved difficult in some animals owing to the complex acoustic properties of the combined signal, a problem reminiscent of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d6dff9475c7dccb35eeb4a0dea0face
https://doi.org/10.1080/09524622.2017.1335617
https://doi.org/10.1080/09524622.2017.1335617
Autor:
Roger R. Dmochowski, Harvey D. Homan, Subbarao V. Yalla, Neil D. Sherman, James S. Cochran, Lawrence Karsh
Publikováno v:
Neurourology and Urodynamics. 35:630-635
Aims The CymActive™ Bladder Management System (BMS) is a self-retaining, intraurethral catheter with a patient-controlled magnetic valve that allows cyclical bladder filling and emptying, without external appliances. We determined the safety and ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9db04687108b1be7b6fe31ca75d6e0dc
https://doi.org/10.1002/nau.22770
https://doi.org/10.1002/nau.22770
Autor:
James S. Cochran, John T. Wei, Mikkel Noerholm, Alan W. Partin, Michael J. Donovan, James M. McKiernan, Peter R. Carroll, Stefan Bentink, Vince O'Neill, Gordon D. Brown, Johan Skog, Susan Belzer, Ian M. Thompson, Gerald L. Andriole
Publikováno v:
Journal of Urology. 193
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96c24d1a714eaa867c5bb0db9bac0a51
https://doi.org/10.1016/j.juro.2015.03.082
https://doi.org/10.1016/j.juro.2015.03.082
Autor:
Gary D. Steinberg, Neal D. Shore, Lawrence Ivan Karsh, James L. Bailen, Trinity Bivalacqua, Karim Chamie, James S. Cochran, Richard David, Robert L. Grubb, Wael A. Harb, Jeffrey M. Holzbeierlein, Ashish M. Kamat, Edouard John Trabulsi, William Vincent Walsh, Michael Brandon Williams, Fredrick Wolk, Michael Woods, Melissa Leigh Price, Brandon Early, Taylor Houghton Schreiber
Publikováno v:
Journal of Clinical Oncology. 35:4531-4531
4531 Background: Vesigenurtacel-L (HS-410) is a vaccine comprised of an allogeneic cell line, selected for high expression from a series of bladder tumor antigens, and transfected with gp96-Ig. Cell-secreted gp96-Ig delivers these cell-derived antige
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::257210f55f9a65c4c48a7af38ad4a5c7
https://doi.org/10.1200/jco.2017.35.15_suppl.4531
https://doi.org/10.1200/jco.2017.35.15_suppl.4531
Autor:
Edouard J. Trabulsi, Richard D. David, Michael B. Williams, Robert L. Grubb, James S. Cochran, Fredrick N. Wolk, Gary D. Steinberg, Trinity J. Bivalacqua, Karim Chamie, Taylor H. Schreiber, James Bailen, Melissa Price, Jeffrey M. Holzbeierlein, William V. Walsh, Neal D. Shore, Ashish M. Kamat, Brandon Early, Michael Woods, Lawrence Karsh, Wael A. Harb
Publikováno v:
Journal of Clinical Oncology. 35:319-319
319 Background: Vesigenurtacel-L (HS-410) is a vaccine comprised of an allogeneic cell line, selected for high expression from a series of bladder tumor antigens, and transfected with gp96-Ig. Cell-secreted gp96-Ig delivers these cell-derived antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87354312dca4da93613f7f24b5e9ae9c
https://doi.org/10.1200/jco.2017.35.6_suppl.319
https://doi.org/10.1200/jco.2017.35.6_suppl.319
Autor:
Harvey D, Homan, Roger, Dmochowski, James S, Cochran, Lawrence, Karsh, Neil D, Sherman, Subbarao, Yalla
Publikováno v:
Neurourology and urodynamics. 35(5)
The CymActive™ Bladder Management System (BMS) is a self-retaining, intraurethral catheter with a patient-controlled magnetic valve that allows cyclical bladder filling and emptying, without external appliances. We determined the safety and efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9e5c4bf39ee86cde2adbbba784fc7370
https://pubmed.ncbi.nlm.nih.gov/25917888
https://pubmed.ncbi.nlm.nih.gov/25917888
Autor:
Igor Dumbadze, Kimberley Rieger-Christ, Todd M. Waldmann, John W. Scott, Kenneth B. Deck, Neal D. Shore, John J. Munoz, Richard D. David, James S. Cochran, Evan B. Krisch, James Bailen, Christopher Michael Pieczonka, Raoul S. Concepcion, Timothy Dean Langford, Scott Asroff, Dipen J. Parekh, Fredrick N. Wolk, Daniel Sjöberg, Michael S. Grable, Ralph Jonathan Henderson, Michael Gambla, Shawn M. McGee, Daniel Saltzstein, Lawrence Karsh, Sanoj Punnen, Daniel W. Lin, Stephen M. Zappala, Paul Sieber
Publikováno v:
European urology. 68(3)
Background The 4Kscore combines measurement of four kallikreins in blood with clinical information as a measure of the probability of significant (Gleason ≥7) prostate cancer (PCa) before prostate biopsy. Objective To perform the first prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3966c5feae059c9e3f473e5c9c615d78
https://pubmed.ncbi.nlm.nih.gov/25454615
https://pubmed.ncbi.nlm.nih.gov/25454615